Leslie Jacobs

Leslie (North) Jacobs, PMP, CCRP, currently serves as the Director of Clinical Affairs at C2N Diagnostics, overseeing daily operations and leading clinical studies to support CMS reimbursement for a blood-based Alzheimer's disease marker test. Previous roles include Director of Clinical Affairs at ELITechGroup Molecular, where Leslie managed clinical and regulatory activities, and Director of Regulatory and Clinical Affairs at Sedia Biosciences Corp., responsible for clinical operations and regulatory submissions. Additional experience encompasses senior project management positions at ICON plc and Novella Clinical, and leadership roles at Biotronik and Hemcon Medical Technologies, focusing on international clinical trials and strategic planning. Jacobs holds a Bachelor of Science in Cellular/Molecular Biology from Humboldt State University.